Docoh
Loading...

ZYXI Zynex

News

From Benzinga Pro
Zynex Q3 EPS $0.17 Beats $0.12 Estimate, Sales $34.80M Miss $35.43M Estimate
2 Nov 21
Earnings, News
Zynex (NASDAQ:ZYXI) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.12 by 41.67 percent. This is a 325 percent increase over earnings of $0.04 per share from the same period
Earnings Scheduled For November 2, 2021
2 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
Earnings Outlook For Zynex
1 Nov 21
Earnings
Zynex (NASDAQ:ZYXI) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement. Analysts estimate that Zynex will likely report an Earnings Per Share (EPS) of $0.12
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
5 Oct 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4)
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
1 Oct 21
Biotech, News, Penny Stocks, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30)
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
30 Sep 21
Biotech, Earnings, M&A, News, Penny Stocks, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29)
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
29 Sep 21
Biotech, M&A, News, Penny Stocks, Small Cap, FDA, IPOs, Top Stories, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28)
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
28 Sep 21
Biotech, News, Penny Stocks, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27)
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
16 Sep 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14)

Press releases

From Benzinga Pro
Zynex to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
24 Nov 21
Press Releases
ENGLEWOOD, Colo., Nov. 24, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke
Zynex Ranked 7th in Revenue Growth Among Medical Device Companies
18 Nov 21
Press Releases
ENGLEWOOD, Colo., Nov. 18, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke
Zynex Declares Special Cash Dividend of $0.10 Per Share and 10% Stock Dividend
10 Nov 21
Dividends, Press Releases
ENGLEWOOD, Colo., Nov. 10, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke
Zynex Celebrates 25th Anniversary
3 Nov 21
Press Releases
ENGLEWOOD, Colo., Nov. 3, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke
Zynex Announces 2021 Third Quarter Earnings
2 Nov 21
Earnings, Press Releases
ENGLEWOOD, Colo., Nov. 2, 2021 /PRNewswire/ -- 2021 Third Quarter Revenue increased 74% year over year
Zynex Schedules 2021 Third Quarter Earnings Call
25 Oct 21
Press Releases
ENGLEWOOD, Colo., Oct. 25, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke
Zynex Announces 70% Order Growth and Increases Q3 2021 Adjusted EBITDA Estimate
13 Oct 21
Earnings, Press Releases
ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke
Zynex to Display its CM-1500 Fluid Monitoring System at the American Society of Anesthesiologists Annual Conference
8 Oct 21
Press Releases
ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke